Home » eNeura’s Migraine Treatment Device Gains FDA Clearance
eNeura’s Migraine Treatment Device Gains FDA Clearance
eNeura received 510(k) clearance for its single-pulse transcranial magnetic stimulation device, which uses electric currents to treat and prevent migraines.
The portable non-invasive device, which is cleared for children 12 and older, delivers a mild electric current that modulates nerve cells in the brain and interrupts hyperactivity associated with migraine headaches.
The device is applied to the back of the head, and a button push delivers the focused magnetic pulse that treats migraine attacks and helps prevent future ones.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May